enmodes is collaborating with various industrial, academic and clinical partners around the world. Therefore, if requested, we can discuss the case with one of our neutral clinical partners and support you preparing your final device to meet all regulatory requirements.
- Department of Cardiovascular Engineering (CVE) of the RWTH University Aachen
- ac.biomed – in-vitro testing and verification of medical devices, prototypes or lab samples
- Materialise – leader in Additive Manufacturing and patient-specific healthcare
- LifeTec Aachen-Jülich e.V. – platform life sciences in the regio Aachen- Jülich
- CADFEM – ANSYS Competence Center FEM
Academic and clinical partners
- Univ.-Prof. Dr.-Ing. Ulrich Steinseifer – Head of the Department of Cardiovascular Engineering (CVE) at the RWTH University Aachen, Germany
- Prof. Mark Slaughter, MD – Director of the Heart Transplant and Mechanical Assist Device program at Jewish Hospital & St. Mary’s HealthCare, as well as chief of the Department of Thoracic and Cardiovascular Surgery at the University of Louisville, USA
- Prof. Dr. Steven Koenig – Professor at the Department of Bioengineering Cardiovascular Innovation Institute, and the Department of Thoracic and Cardiovascular Surgery at the University of Louisville, USA
- Prof. Dr. med. Michael Becker – Senior physician at the Department for Cardiology, Pneumology, Angiology and internistic Intensive-care Medicine at the University Hospital Aachen, Germany
- Dr. med. Sebastian Schulte Eistrup – Senior physician at the cardiac surgery department of the Schüchtermann clinic Bad Rothenfelde, Germany
- Several employees are members of the European Society for Artificial Organs (ESAO)
- Several employees are members of the American Society for Artificial Internal Organs (ASAIO)
- Tim Kaufmann serves as a board member of the International Society for Rotary Blood Pumps (ISRBP)
Research grant for the development of an artificial lung in chronic obstructive pulmonary disease (COPD)
In an alliance of industry, clinic and science, enmodes GmbH, together with the ECMO Centre of the Lung Clinic Cologne-Merheim / University Witten-Herdecke and the University Clinic RWTH Aachen – ECC Research Group of the Institute of Physiology, is researching a lung support system that permanently removes sufficient CO2 from the blood and ultimately enables its use in the home environment. The new development is intended to considerably reduce the risks of existing short-term systems and enable them to be used permanently. Through this approach, the patient should regain a high level of quality of life and self-determination.
The partners will receive a share of EUR 2.1 million from the state of North Rhine-Westphalia and the European Union, more precisely from the European Regional Development Fund (EFRE), for research into the first prototypes. As part of the LifeSciences.NRW lead market competition, around 17 million euros will be paid out to the ten best applications. The consortium was able to prevail against 50 competing project ideas.